Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
200,095
-
Share change
-
+59,663
-
Total reported value
-
$232,108
-
Price per share
-
$1.16
-
Number of holders
-
10
-
Value change
-
+$69,208
-
Number of buys
-
6
-
Number of sells
-
1
Institutional Holders of Estrella Immunopharma, Inc. - COM (ESLA) as of Q3 2024
As of 30 Sep 2024,
Estrella Immunopharma, Inc. - COM (ESLA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
200,095 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, ATW SPAC MANAGEMENT LLC, BlackRock, Inc., VANGUARD GROUP INC, CITADEL ADVISORS LLC, Maso Capital Partners Ltd, UBS Group AG, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, and JPMORGAN CHASE & CO.
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.